Literature DB >> 6304649

Functional analysis of a herpes simplex virus type 1 promoter: identification of far-upstream regulatory sequences.

M G Cordingley, M E Campbell, C M Preston.   

Abstract

We have performed a functional analysis of DNA sequences upstream from the gene for IE mRNA3 of herpes simplex virus type 1. Nucleotide sequences involved in initiation and positive regulation of transcription have been defined by construction of specific deletions in vitro. Transcription was assayed in vivo by microinjection into Xenopus oocytes, or by introduction of plasmid DNA into tissue culture cells and measurement of transient expression. Three functional promoter elements have been defined: i) Sequences between -16 and -37 which are not essential for transcription but are required for accurate initiation. ii) Proximal promoter sequences which are sufficient for transcription initiation in the absence of upstream sequences. iii) Far-upstream promoter sequences (more than 108bp upstream) which increase transcription in oocytes, and contain positive regulatory sequences (-174 to -331) which respond strongly to a factor in the virus inoculum.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304649      PMCID: PMC325889          DOI: 10.1093/nar/11.8.2347

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  49 in total

1.  Regulation of herpesvirus macromolecular synthesis. VIII. The transcription program consists of three phases during which both extent of transcription and accumulation of RNA in the cytoplasm are regulated.

Authors:  P C Jones; B Roizman
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

2.  The cell-free synthesis of herpesvirus-induced polypeptides.

Authors:  C M Preston
Journal:  Virology       Date:  1977-05-01       Impact factor: 3.616

3.  Cruciform structures in supercoiled DNA.

Authors:  N Panayotatos; R D Wells
Journal:  Nature       Date:  1981-02-05       Impact factor: 49.962

4.  DNA sequences necessary for transcription of the rabbit beta-globin gene in vivo.

Authors:  G C Grosveld; E de Boer; C K Shewmaker; R A Flavell
Journal:  Nature       Date:  1982-01-14       Impact factor: 49.962

5.  High efficiency transformation by direct microinjection of DNA into cultured mammalian cells.

Authors:  M R Capecchi
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

6.  Regulation of alpha genes of herpes simplex virus: the alpha 27 gene promoter-thymidine kinase chimera is positively regulated in converted L cells.

Authors:  S Mackem; B Roizman
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

7.  Identification of regulatory sequences in the prelude sequences of an H2A histone gene by the study of specific deletion mutants in vivo.

Authors:  R Grosschedl; M L Birnstiel
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

8.  The ovalbumin gene-sequence of putative control regions.

Authors:  C Benoist; K O'Hare; R Breathnach; P Chambon
Journal:  Nucleic Acids Res       Date:  1980-01-11       Impact factor: 16.971

9.  Altering genotype and phenotype by DNA-mediated gene transfer.

Authors:  A Pellicer; D Robins; B Wold; R Sweet; J Jackson; I Lowy; J M Roberts; G K Sim; S Silverstein; R Axel
Journal:  Science       Date:  1980-09-19       Impact factor: 47.728

10.  Herpes simplex virus gene expression in transformed cells. I. Regulation of the viral thymidine kinase gene in transformed L cells by products of superinfecting virus.

Authors:  J M Leiden; R Buttyan; P G Spear
Journal:  J Virol       Date:  1976-11       Impact factor: 5.103

View more
  54 in total

1.  Temperature-dependent conformational changes in herpes simplex virus ICP4 that affect transcription activation.

Authors:  Peter Compel; Neal A DeLuca
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Association of ICP0 but not ICP27 with purified virions of herpes simplex virus type 1.

Authors:  F Yao; R J Courtney
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  Enhanced infectivity of herpes simplex virus type 1 viral DNA in a cell line expressing the trans-inducing factor Vmw65.

Authors:  G Werstuck; P Bilan; J P Capone
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

4.  Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression.

Authors:  C I Ace; T A McKee; J M Ryan; J M Cameron; C M Preston
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

5.  Herpes simplex virus immediate-early promoters are responsive to virus and cell trans-acting factors.

Authors:  I H Gelman; S Silverstein
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

6.  Dissection of immediate-early gene promoters from herpes simplex virus: sequences that respond to the virus transcriptional activators.

Authors:  I H Gelman; S Silverstein
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

7.  Physical and functional domains of the herpes simplex virus transcriptional regulatory protein ICP4.

Authors:  N A DeLuca; P A Schaffer
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

8.  Association of herpes simplex virus regulatory protein ICP4 with sequences spanning the ICP4 gene transcription initiation site.

Authors:  S W Faber; K W Wilcox
Journal:  Nucleic Acids Res       Date:  1988-01-25       Impact factor: 16.971

9.  Replication origins and a sequence involved in coordinate induction of the immediate-early gene family are conserved in an intergenic region of herpes simplex virus.

Authors:  J L Whitton; J B Clements
Journal:  Nucleic Acids Res       Date:  1984-02-24       Impact factor: 16.971

10.  Expression of the chloramphenicol acetyltransferase gene in mammalian cells under the control of adenovirus type 12 promoters: effect of promoter methylation on gene expression.

Authors:  I Kruczek; W Doerfler
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.